tiprankstipranks
Advertisement
Advertisement
AI Models Diverge on GoodRx as Technical Momentum Meets Legacy Headwinds
PremiumAI Analyst RatingsAI Models Diverge on GoodRx as Technical Momentum Meets Legacy Headwinds
1M ago
AI Models Split on GoodRx: Momentum vs. Revenue Risk in Focus
Premium
AI Analyst Ratings
AI Models Split on GoodRx: Momentum vs. Revenue Risk in Focus
1M ago
GoodRx price target raised to $4 from $3.50 at Citi
Premium
The Fly
GoodRx price target raised to $4 from $3.50 at Citi
1M ago
Notable companies reporting after market close
PremiumThe FlyNotable companies reporting after market close
1M ago
GoodRx reports Q1 adjusted EPS 7c, consensus 7c
Premium
The Fly
GoodRx reports Q1 adjusted EPS 7c, consensus 7c
1M ago
GoodRx raises FY26 revenue view to $765M-$785M from $750M-$780M
Premium
The Fly
GoodRx raises FY26 revenue view to $765M-$785M from $750M-$780M
1M ago
GoodRx Reshapes Board After Director Resignation and Reclassification
PremiumCompany AnnouncementsGoodRx Reshapes Board After Director Resignation and Reclassification
3M ago
GoodRx Chief Accounting Officer Resigns for New Opportunity
Premium
Company Announcements
GoodRx Chief Accounting Officer Resigns for New Opportunity
3M ago
GoodRx announces resignation of Chief Accounting Officer Romin Nabiey
Premium
The Fly
GoodRx announces resignation of Chief Accounting Officer Romin Nabiey
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100